Incentivising the development of new antibacterial treatments 2023

Incentivising the development of new antibacterial treatments 2023

A new report from the World Health Organization (WHO) on the development of new antibacterial drugs has been published.

In 2019, more than 4.9 million deaths were due to bacterial antimicrobial resistance (AMR). It remains one of the top 10 global public health threats.

Moreover, antimicrobial resistance has negative economic consequences: it leads to an increase in the cost of healthcare and the production of medicines. By 2050, the cumulative economic losses from AMR are projected to be over $100 trillion.

WHO's main recommendations for combating AMR include ensuring the sustainability of the supply and availability of antibiotics, stimulating research and developing new antibacterial drugs that meet public health needs.

Print   Email

Website of the Accounts Chamber of the Russian Federation International Activities

Privacy Policy

We use cookies and collect technical impersonal information about you to improve the performance of our website. You can find a detailed description of how we use your data information in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy. By clicking on the "Accept & Close" button, you provide your explicit consent to the processing of your data to achieve the above goal. You can withdraw your consent using the method specified in the Privacy Policy.